These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9746588)

  • 1. Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway.
    Zhang MX; Kozel TR
    Infect Immun; 1998 Oct; 66(10):4845-50. PubMed ID: 9746588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans.
    Zhang MX; Lupan DM; Kozel TR
    Infect Immun; 1997 Sep; 65(9):3822-7. PubMed ID: 9284158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans.
    Boxx GM; Nishiya CT; Kozel TR; Zhang MX
    Mol Immunol; 2009 Jan; 46(3):473-80. PubMed ID: 19038459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of IgG Subclass on Human Antimannan Antibody-Mediated Resistance to Hematogenously Disseminated Candidiasis in Mice.
    Nishiya CT; Boxx GM; Robison K; Itatani C; Kozel TR; Zhang MX
    Infect Immun; 2016 Feb; 84(2):386-94. PubMed ID: 26573736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activities of naturally occurring antibodies reactive with Candida albicans mannan.
    Kozel TR; MacGill RS; Percival A; Zhou Q
    Infect Immun; 2004 Jan; 72(1):209-18. PubMed ID: 14688098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting roles of mannan-specific monoclonal immunoglobulin M antibodies in the activation of classical and alternative pathways by Candida albicans.
    Zhang MX; Cutler JE; Han Y; Kozel TR
    Infect Immun; 1998 Dec; 66(12):6027-9. PubMed ID: 9826391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans.
    Kozel TR; Weinhold LC; Lupan DM
    Infect Immun; 1996 Aug; 64(8):3360-8. PubMed ID: 8757876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.
    Boxx GM; Kozel TR; Nishiya CT; Zhang MX
    Infect Immun; 2010 Mar; 78(3):1250-9. PubMed ID: 20028806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific in vitro antimannan-rich antigen of Candida albicans antibody production by sensitized human blood lymphocytes.
    Durandy A; Fischer A; Griscelli C
    J Clin Invest; 1983 Jun; 71(6):1602-13. PubMed ID: 6345586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and binding of C3 by Candida albicans.
    Kozel TR; Brown RR; Pfrommer GS
    Infect Immun; 1987 Aug; 55(8):1890-4. PubMed ID: 3301679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice.
    Zhang MX; Bohlman MC; Itatani C; Burton DR; Parren PW; St Jeor SC; Kozel TR
    Infect Immun; 2006 Jan; 74(1):362-9. PubMed ID: 16368991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the alternative complement pathway by the immune precipitate formed with F(ab')2 fragment of human IgG antibody.
    Akagaki Y; Inai S
    Mol Immunol; 1983 Nov; 20(11):1221-6. PubMed ID: 6419059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans.
    Jones JM
    Infect Immun; 1980 Oct; 30(1):78-89. PubMed ID: 7002793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.
    Zhang MX; Klein B
    Infect Immun; 1997 May; 65(5):1849-55. PubMed ID: 9125571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A β-mannan trisaccharide conjugate vaccine aids clearance of Candida albicans in immunocompromised rabbits.
    Lipinski T; Wu X; Sadowska J; Kreiter E; Yasui Y; Cheriaparambil S; Rennie R; Bundle DR
    Vaccine; 2012 Sep; 30(44):6263-9. PubMed ID: 22902677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalency is required for anticapsular monoclonal antibodies to optimally suppress activation of the alternative complement pathway by the Cryptococcus neoformans capsule.
    Kozel TR; MacGill RS; Wall KK
    Infect Immun; 1998 Apr; 66(4):1547-53. PubMed ID: 9529080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential humoral response against alpha- and beta-linked mannose residues associated with tissue invasion by Candida albicans.
    Jouault T; Delaunoy C; Sendid B; Ajana F; Poulain D
    Clin Diagn Lab Immunol; 1997 May; 4(3):328-33. PubMed ID: 9144372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.
    Joiner KA; Scales R; Warren KA; Frank MM; Rice PA
    J Clin Invest; 1985 Nov; 76(5):1765-72. PubMed ID: 3932472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of circulating Candida albicans mannan and antimannan antibodies: useful for diagnosis of deep seated candidiasis].
    Eloy O; Tabella C; Harzic M; Pina P; Allouch P; Pangon B; Bedos JP; Ghnassia JC
    Ann Biol Clin (Paris); 2002; 60(6):711-4. PubMed ID: 12446238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.